Susan Rodriguez

Insider Reports History

Location
Chicago, IL
Signature
/s/ Robert E. Puopolo, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan Rodriguez:

Company Role Class Num Shares Value Price $ Report Date Ownership
ARDELYX, INC. Chief Commercial Officer Common Stock 449,092 $3,507,858 $7.81 21 May 2024 Direct
Veradigm Inc. Director Common Stock 88,618 $381,057 $4.30 02 Jun 2025 Direct
ARDELYX, INC. Chief Commercial Officer Stock Option (Right to Buy) 145,000 $336,400 $2.32 16 Jan 2024 Direct
HERON THERAPEUTICS, INC. /DE/ Director Common Stock 87,180 $230,155 $2.64 31 Jan 2025 Direct
HERON THERAPEUTICS, INC. /DE/ Director Stock Option (Right to Buy) 35,900 $62,107 $1.73 31 Jan 2025 Direct
AVADEL PHARMACEUTICALS PLC Chief Operating Officer Stock Option (Right to Buy) 0 12 Feb 2026 Direct

Insider Reports Filed by Susan Rodriguez

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVDL AVADEL PHARMACEUTICALS PLC 12 Feb 2026 1 $0 4 Chief Operating Officer 12 Feb 2026, 17:36
MDRX Veradigm Inc. 02 Jun 2025 1 +$200,002 4 Director 03 Jun 2025, 19:43
AVDL AVADEL PHARMACEUTICALS PLC 13 May 2025 1 $0 4 Chief Operating Officer 13 May 2025, 18:01
AVDL AVADEL PHARMACEUTICALS PLC 13 May 2025 0 $0 3 Chief Operating Officer 13 May 2025, 18:00
HRTX HERON THERAPEUTICS, INC. /DE/ 31 Jan 2025 2 $0 4/A Director 04 Feb 2025, 17:27
HRTX HERON THERAPEUTICS, INC. /DE/ 30 Jan 2025 2 +$62,107 4 Director 03 Feb 2025, 11:33
MDRX Veradigm Inc. 31 May 2024 1 $0 4 Director 20 Jun 2024, 17:00
ARDX ARDELYX, INC. 21 May 2024 1 -$52,357 4 Chief Commercial Officer 23 May 2024, 16:17
ARDX ARDELYX, INC. 20 Feb 2024 1 -$60,594 4 Chief Commercial Officer 22 Feb 2024, 16:56
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jan 2024 2 $0 4 Director 19 Jan 2024, 21:04
ARDX ARDELYX, INC. 16 Jan 2024 2 $0 4 Chief Commercial Officer 18 Jan 2024, 16:37
ARDX ARDELYX, INC. 20 Nov 2023 1 -$20,563 4 Chief Commercial Officer 22 Nov 2023, 17:20
ARDX ARDELYX, INC. 21 Aug 2023 1 -$16,811 4 Chief Commercial Officer 23 Aug 2023, 16:48
ARDX ARDELYX, INC. 23 May 2023 1 -$17,210 4 Chief Commercial Officer 25 May 2023, 08:52
ARDX ARDELYX, INC. 21 Feb 2023 1 -$16,764 4 Chief Commercial Officer 02 Mar 2023, 15:36
MDRX Veradigm Inc. 17 Feb 2023 0 $0 3 Director 27 Feb 2023, 16:27
ARDX ARDELYX, INC. 05 Jan 2023 2 $0 4 Chief Commercial Officer 06 Jan 2023, 15:24
HRTX HERON THERAPEUTICS, INC. /DE/ 16 Dec 2022 2 $0 4 Director 20 Dec 2022, 16:21
ARDX ARDELYX, INC. 22 Nov 2022 3 -$6,736 4 Chief Commercial Officer 23 Nov 2022, 15:15
ARDX ARDELYX, INC. 22 Aug 2022 2 -$3,364 4 Chief Commercial Officer 24 Aug 2022, 17:45
ARDX ARDELYX, INC. 06 Jun 2022 2 -$28,574 4 Chief Commercial Officer 08 Jun 2022, 20:02
ARDX ARDELYX, INC. 20 May 2022 1 -$2,300 4 Chief Commercial Officer 23 May 2022, 16:35
ARDX ARDELYX, INC. 22 Feb 2022 1 -$2,278 4 Chief Commercial Officer 25 Feb 2022, 15:54
ARDX ARDELYX, INC. 06 Jan 2022 2 $0 4 Chief Commercial Officer 12 Jan 2022, 18:47
HRTX HERON THERAPEUTICS, INC. /DE/ 22 Dec 2021 2 $0 4 Director 23 Dec 2021, 17:58
ARDX ARDELYX, INC. 22 Nov 2021 1 -$638 4 Chief Commercial Officer 24 Nov 2021, 15:08
ARDX ARDELYX, INC. 08 Oct 2021 1 $0 4 Chief Commercial Officer 29 Oct 2021, 19:56
HRTX HERON THERAPEUTICS, INC. /DE/ 20 Sep 2021 0 $0 3 Director 29 Sep 2021, 16:18
ARDX ARDELYX, INC. 20 Aug 2021 1 -$832 4 Chief Commercial Officer 24 Aug 2021, 18:07
ARDX ARDELYX, INC. 20 May 2021 1 -$4,331 4 Chief Commercial Officer 21 May 2021, 16:49